Biodiversity and Human HealthThe implications of biodiversity loss for the global environment have been widely discussed, but only recently has attention been paid to its direct and serious effects on human health. Biodiversity loss affects the spread of human diseases, causes a loss of medical models, diminishes the supplies of raw materials for drug discovery and biotechnology, and threatens food production and water quality.Biodiversity and Human Health brings together leading thinkers on the global environment and biomedicine to explore the human health consequences of the loss of biological diversity. Based on a two-day conference sponsored by the National Institutes of Health, the National Science Foundation, and the Smithsonian Institution, the book opens a dialogue among experts from the fields of public health, biology, epidemiology, botany, ecology, demography, and pharmacology on this vital but often neglected concern.Contributors discuss the uses and significance of biodiversity to the practice of medicine today, and develop strategies for conservation of these critical resources. Topics examined include: the causes and consequences of biodiversity loss emerging infectious diseases and the loss of biodiversity the significance and use of both prescription and herbal biodiversity-derived remedies indigenous and local peoples and their health care systems sustainable use of biodiversity for medicine an agenda for the future In addition to the editors, contributors include Anthony Artuso, Byron Bailey, Jensa Bell, Bhaswati Bhattacharya, Michael Boyd, Mary S. Campbell, Eric Chivian, Paul Cox, Gordon Cragg, Andrew Dobson, Kate Duffy-Mazan, Robert Engelman, Paul Epstein, Alexandra S. Fairfield, John Grupenhoff, Daniel Janzen, Catherine A. Laughin, Katy Moran, Robert McCaleb, Thomas Mays, David Newman, Charles Peters, Walter Reid, and John Vandermeer.The book provides a common framework for physicians and biomedical researchers who wish to learn more about environmental concerns, and for members of the environmental community who desire a greater understanding of biomedical issues. |
Comentarios de la gente - Escribir un comentario
No encontramos ningún comentario en los lugares habituales.
Contenido
Global Environmental Degradation and Biodiversity Loss Implications for Human Health | 7 |
Earthly Dominion Population Growth Biodiversity and Health | 39 |
Biodiversity and Emerging Infectious Diseases Integrating Health and Ecosystem Monitoring | 60 |
Fatal Synergisms Interactions between Infectious Diseases Human Population Growth and Loss of Biodiversity | 87 |
Biodiversity Loss in and around Agroecosystems | 111 |
Drug Discovery from Biological Diversity | 129 |
The Origins of Prescription Drugs | 131 |
Natural Products for the Treatment of Infectious Diseases | 164 |
Returning Benefits from Ethnobotanical Drug Discovery to Native Communities | 243 |
An Agenda for the Future Conserving Biodiversity and Human Health | 265 |
A Paradigm for the Equitable Sharing of Benefits Resulting from Biodiversity Research and Development | 267 |
Integrating Drug Discovery Biodiversity Conservation and Economic Development Early Lessons from the International Cooperative Biodiversity Gr... | 281 |
Causes and Consequences of Biodiversity Loss Liquidation of Natural Capital and Biodiversity Resource Development in Costa Rica | 302 |
Sustainable Use of Biodiversity Myths Realities and Potential | 312 |
Opportunities for Collaboration between the Biomedical and Conservation Communities | 334 |
A Proposal for a National Council on Biodiversity and Human Health | 353 |
Capturing the Chemical Value of Biodiversity Economic Perspectives and Policy Prescriptions | 184 |
Biodiversity and Traditional Health Systems | 205 |
Indigenous Peoples and Conservation | 207 |
Medicinal Plants for Healing the Planet Biodiversity and Environmental Health Care | 221 |
Contributors | 357 |
361 | |
Otras ediciones - Ver todas
Términos y frases comunes
activity agents agricultural American animal areas associated become benefits biodiversity biological Cancer cause Chapter chemical climate collection communities compensation compounds conservation continue costs culture derived disease diversity drug drug discovery economic ecosystems effects emergence environment environmental established et al example extinction extracts forest funds future genetic global groups growth habitat harvest host human health ICBG impacts important increase indigenous industry infections infectious diseases Institute International involved isolated knowledge land lead levels living loss major material medicinal medicinal plants million natural products organisms parasitic pathogens pharmaceutical plants policies population possible potential present Press projects prospecting recent reduce region response result samples Science scientific screening Society source country species sustainable synthetic testing tion traditional treat tree tropical United University York
Pasajes populares
Página xix - National Institute of Neurological Disorder and Stroke National Institute of Allergy and Infectious Diseases National Institute of General Medical Sciences...